Cancer Institute NSW Board
There are currently ten members of the Cancer Institute NSW Board.
The Hon Morris Iemma BEc LLB
Chairperson of the Board of the Cancer Institute
NSW
Mr Iemma served as a Member of Parliament in the NSW Legislative
Assembly for 17 years 3 months from May 1991 until September 2008.
He held a number of Ministerial portfolios including Premier,
Treasurer, Minister for Health, Minister for Sport and Recreation,
Minister for Public Works and Services, Minister for State
Development and Minister Assisting the Premier on Citizenship. He
has a BEc degree from the University of Sydney and an LLB from the
University of Technology, Sydney.
Professor David Currow BMed MPH FRACP
Chief Cancer Officer and CEO
Professor Currow is Chief Cancer Officer and CEO of the Cancer
Institute NSW. Prior to this he was the foundation Chief Executive
Officer of Cancer Australia, the Australian Government's national
cancer control agency. Professor Currow initially trained as a
physician in internal medicine with sub-speciality training in
palliative medicine and he completed a Master of Public Health
exploring changes in the reported incidence of cancer unknown
primary in New South Wales over a 25 year time period.
Former roles include foundation Director of the Nepean Cancer Care
Centre, Sydney and Area Director of Palliative Services Wentworth
Area Health Service, Sydney. Since 2000 he has held the Chair of
Palliative and Supportive Services at Flinders University. He has
published widely in palliative care journals and the general
medical literature. He is a former president of the Clinical
Oncological Society of Australia and a former president of
Palliative Care Australia, the peak body for palliative care in the
country.
Mr Keith Cox OAM NP
Mr Cox is a nurse practitioner in the oncology chemotherapy unit
at Sydney's Royal Prince Alfred Hospital (RPA). He was authorised
as a nurse practitioner in 2005 and prior to this he acted in a
clinical nurse consultant role. He is a Senior Clinical
Lecturer at the University of Sydney. Mr Cox has travelled to
Nepal and Papua New Guinea to help set up oncology units and to
train local nurses. He is also a member of the Cancer Nursing
Society of Australia and Chair of their Winter Congress Committee.
He also works in other community areas including CanTeen, St
Vincent de Paul and volunteering through his local parish. Mr Cox
was awarded an OAM in 2007 for his services to nursing and
community volunteer work.
Sally Goss MA, Grad Dip Nurs, RN
Ms Goss is currently a board member of the National
Gynaecological Cancer Foundation and has previous board experience
with Family Planning NSW, Mental Illness Education Australia and
Petrea King's Quest for Life. Ms Goss's professional career has
included working with BreastScreen NSW at both local and state
level. At Family Planning NSW she worked in a range of clinical,
research and management roles culminating in her appointment as
Manager Clinical Services and Chief Nurse.
In recent years Ms Goss has worked closely with, and been a
strong advocate for women living with gynaecological cancers having
completed a research project and subsequently convening a
fundraising group. She was awarded a Churchill Fellowship in 2009
travelling to Canada, USA and UK to examine differing models of
psychosocial care.
Professor Peter Gunning BSc(Hons), PhD
Professor Gunning is the Head of the Oncology Research Unit in
the Department of Anatomy at the University of New South Wales. His
research is focussed on the development of new therapeutic
strategies for the treatment of childhood cancer. These strategies
target the skeleton of the cancer cell and build on the principles
of cell architecture that Professor Gunning's group has discovered
over the last 20 years.
Professor Gunning has published over 100 primary research
articles and has recently edited the first book devoted to his
field of research. Previous appointments have included leadership
roles as Chair of the Division of Research at The Children's
Hospital at Westmead, Chair of the Westmead Research Hub Executive
and the Founding Chair of Bio-Link, a company established by
the NSW Government to support commercialisation of biomedical
intellectual property.
Dr Paul Moy BA (Hons-Ec), Dip Ed, PhD(Ec)
Dr Moy is Global Head of Infrastructure and Private Equity,
UBS Global Asset Management, based in London and has 21 years of
investment industry experience. He has extensive experience in
banking and principal investment internationally, as well as public
policy in the early part of his career. Dr Moy is an experienced
company director of both private and public companies, as well as
non-profit organisations.
Professor Michael Solomon MBBCh, BAO, MSc, FRACS
Professor Michael Solomon is a consultant surgeon and Academic
Head of the Department of Colorectal Surgery at the Royal Prince
Alfred Hospital in Sydney. He is a Clinical Professor of Surgery
and Director of Colorectal Research, both for Royal Prince Alfred
Hospital and the University of Sydney and is a past the President
of the Colorectal Surgical Society of Australia & New Zealand
(CSSANZ). He is on the editorial board of DCR, Colorectal Disease
& Int J Colorectal Diseases.
Professor Solomon has published over 192 papers and obtained
over 9 million dollars in peer reviewed research grants. He
is the Founding Director and Head of the Surgical Outcomes Research
Centre (SOuRCe) at the University of Sydney which was established
as a multidisciplinary, academic research unit dedicated to the
advancement of evidence-based surgical practice through the conduct
of outcomes-orientated surgical research. Professor Solomon's
surgical expertise is in multi-disciplined complex pelvic surgery
for advanced and recurrent malignancy, inflammatory bowel disease
and pelvic floor disorders as well as laparoscopic colorectal
surgery. His current research interests lie in developing maximally
invasive techniques for advanced pelvic malignancy, clinical trials
of minimally invasive colorectal surgery and the assessment and
performance of randomised and alternative clinical trial designs
for surgical operations.
Mr John Stubbs BA Dip Acct
Mr Stubbs holds government positions at both board and
committee levels. He is a survivor of Leukaemia and an active
representative of cancer consumers. He is an Honorary
Associate of the University of Sydney, School of Medicine and
member of the Radiation Oncology Workforce Committee. Mr
Stubbs is the Australian Consumer representative on the
International Colon Cancer Familial Register funded through the
National Cancer Institute (NCI) in the US. He has contributed to a
number of booklets, including Cancer how are you
travelling; research papers; an editor of the Asia Pacific
Journal of Clinical Oncology; edited consumer booklets for the
Cancer Council; and is an active contributor to Government policy
on cancer, cancer services and the value of consumer
involvement.
Ms Lucy Turnbull AO LLB MBA
Ms Turnbull is a businesswoman and company director.
She was Lord Mayor of the City of Sydney from 2003 to 2004 and
Deputy Lord Mayor from 1999 to 2003. Ms Turnbull was Deputy
Chair of the COAG Reform Council's Cities Expert Advisory Panel.
She chairs ASX listed Prima Biomed Limited, and is a board member
of the Australian Technology Park. She is active in the
not-for-profit sector and is a board member of the US Studies
Centre at the University of Sydney, the Biennale of Sydney and
the Redfern Foundation. In 2011 she was made an Officer of the
Order of Australia for her services to the community, local
government ad business. In 2012 she was awarded an honorary
doctorate in business administration from the University of New
South Wales.
Professor Robyn Ward MBBS PhD FRACP
Professor Ward is the Clinical Associate Dean, Prince of
Wales Clinical School, University of NSW. She is a specialist
medical oncologist at Prince of Wales Hospital, Sydney and also
leads the adult cancer research program in the Lowy Cancer Research
Centre. Amongst other roles, Robyn serves as a member fo the
Commonwealth's Pharmaceutical Benefits Advisory Committee, and was
appointed in 2009 as Chair of the Medical Services Advisory
Committee. She is also a member of the National Health and Medical
Research Council and Chair of its Human Genetics Advisory
Committee.
Top of page
